ASP ISOTOPES INC - Form 8-K Current Report and Rule 425 Written Communication Related to a Business Combination

Form 8-K Current Report and Rule 425 Written Communication Related to a Business Combination

ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")

SCHEDULE 13D - GENERAL STATEMENT OF ACQUISITION OF BENEFICIAL OWNERSHIP AND
FORM 3 - INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

ASPI stockholders are advised that on 8 October 2026, a Schedule 13D and Form 3 have been filed with
the U.S. Securities and Exchange Commission.

Copies of the Schedule 13D and Form 3 can be found at: SCHEDULE_13D and SEC FORM 3.

The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.

9 October 2026

Sponsor
Valeo Capital Proprietary Limited
Date: 09/10/2026 07:19:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.